Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

Comprensorio Amedeo Di Savoia Birago Di Vische, Torino

Hopital Sainte Marguerite - Hospital, Marseille

IRCCS A.O.U. San Martino, Genova

Fondazione IRCCS San Raffaele del Monte Tabor, Milan

ICH Study Center- Dedicated Research, Hamburg

ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milan

Hospital Universitario 12 de Octubre - Hospital, Madrid

Hospital Universitario La Paz, Madrid

Orlando Immunology Center, Orlando

Triple O Research Institute PA, West Palm Beach

Midway Immunology & Research Center, LLC, Ft. Pierce

CHU Tours Service de Médecine Internes et Maladies Infectieuses, Tours

CHU de Nantes, Nantes

CHR Orleans la Source, Orléans

Universitatsklinikum Essen, Essen

Universitat Mainz, Mainz

Hopital Saint Louis, Paris

Hopital Necker les Enfants Malades, Paris

CHU de Nice-l Archet, Nice

Hospital Universitari Germans Trias i Pujol, Badalona

Hospital Clinic de Barcelona - Hospital, Barcelona